BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5325555)

  • 1. [Etiopathogenic considerations on multiple sclerosis with particular regard to the autoimmune hypothesis].
    Giunta A; Palchetti R; Tortoli V
    Rass Neurol Veg; 1965 Apr; 19(1):71-122. PubMed ID: 5325555
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etiopathogenic hypotheses of multiple sclerosis].
    Caputo D; Zibetti A; Ghezzi A; Di Costanzo M
    Arch Sci Med (Torino); 1980; 137(4):673-7. PubMed ID: 6941748
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple sclerosis--a receptor disease? Etiopathogenic considerations].
    Kríz K
    Cesk Neurol Neurochir; 1984 Sep; 47(5):333-4. PubMed ID: 6096031
    [No Abstract]   [Full Text] [Related]  

  • 4. [Perivenous encephalomyelitis and multiple sclerosis].
    Werner W
    Med Klin; 1969 Oct; 64(42):1924-7. PubMed ID: 5357972
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].
    Aleksandrowicz J; Blicharski J; Skotnicki A; Retinger M; Zduńczyk A
    Pol Tyg Lek; 1981 Aug; 36(35):1363-5. PubMed ID: 7036112
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment on "hypothesis-ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers" by W.B. Grant, Photochem. Photobiol. (2007).
    Norval M; Woods GM
    Photochem Photobiol; 2008; 84(3):802-5; author reply 806-8. PubMed ID: 18435623
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple sclerosis. Recent concepts of etiology.
    Davis TE
    Minn Med; 1974 Dec; 57(12):955-7. PubMed ID: 4421490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multiple sclerosis].
    Steck AJ
    Rev Med Suisse Romande; 1984 Mar; 104(3):231-8. PubMed ID: 6326241
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multiple sclerosis. Studies on etiology and therapy].
    Bauer HJ
    MMW Munch Med Wochenschr; 1982 Jan; 124(4):69-70. PubMed ID: 6801481
    [No Abstract]   [Full Text] [Related]  

  • 10. [Multiple sclerosis: advances in its pathogenesis].
    Godoy J; Court J
    Rev Med Chil; 1982 Jun; 110(6):581-4. PubMed ID: 6761822
    [No Abstract]   [Full Text] [Related]  

  • 11. [Etiology and physiopathology of multiple sclerosis].
    Itoyama Y; Fujiwara K; Nakashima I; Sato S
    Nihon Naika Gakkai Zasshi; 1998 Apr; 87(4):604-11. PubMed ID: 9627466
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the pathogenesis of multiple sclerosis. IV. Post-infectious (measles) encephalitis.
    Courville CB
    Bull Los Angeles Neurol Soc; 1965 Sep; 30(3):131-41. PubMed ID: 5847971
    [No Abstract]   [Full Text] [Related]  

  • 13. Experimental allergic encephalomyelitis as a guide to the understanding and treatment of multiple sclerosis.
    Whitaker JN; Mitchell GW
    Ann Neurol; 1993 Nov; 34(5):636-7. PubMed ID: 8239557
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dyslipoproteinemia in the pathogenesis of disseminated sclerosis].
    Akimov GA; Golovkin VI; Matveeva TS; Pleskov VM
    Sov Med; 1984; (5):54-7. PubMed ID: 6463723
    [No Abstract]   [Full Text] [Related]  

  • 15. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

  • 16. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multiple sclerosis--immunopathogenesis, traditional therapeutic strategy and suggested combined immunotherapy].
    Skotnicki AB; Aleksandrowicz J; Retinger-Grzesiuła M; Zduńczyk A; Grochmal S; Huczyński J
    Postepy Hig Med Dosw; 1983; 37(1):1-32. PubMed ID: 6356094
    [No Abstract]   [Full Text] [Related]  

  • 18. [Multiple sclerosis and experimental autoimmune encephalomyelitis].
    Béraud-Juven E
    Rev Prat; 1994 Jan; 44(1):69-74. PubMed ID: 8178062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of methallothioneins in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Espejo C; Martínez-Cáceres EM
    Ann N Y Acad Sci; 2005 Jun; 1051():88-96. PubMed ID: 16126947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease.
    Hafler DA; Weiner HL
    Chem Immunol; 1995; 60():126-49. PubMed ID: 7857525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.